News

Candida auris is an emerging yeast that is causing numerous outbreaks in health care settings, and life-threatening infections in patients worldwide.1 Most isolates of C. auris are multidrug resistant.

The Clinical and Laboratory Standards Institute (CLSI) has published the second edition of QMS15—Laboratory Internal Audit Program. This guideline provides recommendations for establishing an internal audit program and related processes for enhanced quality and continual improvement in the laboratory.

The Clinical and Laboratory Standards Institute (CLSI) has published the second edition of M47—Principles and Procedures for Blood Cultures.

Biotech executive, Barbara J. Jones, Ph.D., has been named Chief Executive Officer of the Clinical and Laboratory Standards Institute (CLSI) effective May 16, 2022. The current CLSI CEO, Glen Fine, announced his retirement in January 2022 and is set to depart the organization after 17 years at the helm.

The Clinical and Laboratory Standards Institute (CLSI) has published M100—Performance Standards for Antimicrobial Susceptibility Testing, 32nd Edition.

CLSI announces the election of three new Board members. Serving as new Directors are Collette Fitzgerald, PhD, Tania Motschman, MS, MT(ASCP)SBB, and Susan Sharp, PhD, D(ABMM), F(AAM).

The Clinical and Laboratory Standards Institute (CLSI) has published the 5th edition of M39—Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data. This guideline describes methods for recording and analyzing antimicrobial susceptibility test data, consisting of cumulative and ongoing summaries of susceptibility patterns of clinically significant microorganisms.

The Clinical and Laboratory Standards Institute announces the recipients of its 2022 Excellence Awards. These awards celebrate the achievements of CLSI volunteers who have helped improve the quality of medical care worldwide.

The Clinical and Laboratory Standards Institute (CLSI) has published the first edition of guideline EP39—A Hierarchical Approach to Selecting Surrogate Samples for the Evaluation of In Vitro Medical Laboratory Tests.